Glucaric acid

Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Glucaric acid?

Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Glucaric acid

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Hypercalcemia D006934 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Lung Neoplasms D008175 171 associated lipids
Mycobacterium Infections D009164 7 associated lipids
Kidney Neoplasms D007680 29 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Esophageal Neoplasms D004938 20 associated lipids
Precancerous Conditions D011230 48 associated lipids
Carbon Tetrachloride Poisoning D002252 12 associated lipids
Femoral Neck Fractures D005265 3 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Heart Failure D006333 36 associated lipids
Per page 10 20 50 100 | Total 85

PubChem Associated disorders and diseases

What pathways are associated with Glucaric acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Glucaric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Glucaric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Glucaric acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with Glucaric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Glucaric acid?

Knock-out

Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Glucaric acid

Download all related citations
Per page 10 20 50 100 | Total 1061
Authors Title Published Journal PubMed Link
Sricholpech M et al. Lysyl hydroxylase 3-mediated glucosylation in type I collagen: molecular loci and biological significance. 2012 J. Biol. Chem. pmid:22573318
Wyffels L et al. Detection of myocardial ischemia-reperfusion injury using a fluorescent near-infrared zinc(II)-dipicolylamine probe and 99mTc glucarate. 2012 Mol Imaging pmid:22554483
Monsénégo J et al. Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis. 2012 J. Hepatol. pmid:22037024
Ozkurt S et al. Acute and subacute effects of EV iron sucrose on endothelial functions in hemodialysis patients. 2012 Ren Fail pmid:22017464
Toblli JE et al. Comparison of oxidative stress and inflammation induced by different intravenous iron sucrose similar preparations in a rat model. 2012 Inflamm Allergy Drug Targets pmid:22309085
Stachowska-Pietka J et al. Computer simulations of osmotic ultrafiltration and small-solute transport in peritoneal dialysis: a spatially distributed approach. 2012 Am. J. Physiol. Renal Physiol. pmid:22301624
Muñoz M et al. Effects of postoperative intravenous iron on transfusion requirements after lower limb arthroplasty. 2012 Br J Anaesth pmid:22337966
Freburger JK et al. Changing patterns of anemia management in US hemodialysis patients. 2012 Am. J. Med. pmid:22938926
Christoph P et al. Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose. 2012 J Perinat Med pmid:22945271
Rostoker G et al. Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: a MRI study. 2012 Am. J. Med. pmid:22998881
Okam MM et al. Comparative rates of adverse events with different formulations of intravenous iron. 2012 Am. J. Hematol. pmid:22965928
Borchard G et al. Nanoparticle iron medicinal products - Requirements for approval of intended copies of non-biological complex drugs (NBCD) and the importance of clinical comparative studies. 2012 Regul. Toxicol. Pharmacol. pmid:22951348
Smith AA et al. The CanOE strategy: integrating genomic and metabolic contexts across multiple prokaryote genomes to find candidate genes for orphan enzymes. 2012 PLoS Comput. Biol. pmid:22693442
De Sousa A and Kalra G Drug therapy of attention deficit hyperactivity disorder: current trends. 2012 Mens Sana Monogr pmid:22654382
Ceretta LB et al. Increased oxidative stress and imbalance in antioxidant enzymes in the brains of alloxan-induced diabetic rats. 2012 Exp Diabetes Res pmid:22645603
Yamamoto S et al. Fibroblast growth factor 23-related osteomalacia caused by the prolonged administration of saccharated ferric oxide. 2012 Intern. Med. pmid:22975552
Bidossi A et al. A functional genomics approach to establish the complement of carbohydrate transporters in Streptococcus pneumoniae. 2012 PLoS ONE pmid:22428019
Galutira PJ and Del Rio M Understanding renal posttransplantation anemia in the pediatric population. 2012 Pediatr. Nephrol. pmid:22086345
Ernst MC et al. Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance. 2012 Endocrinology pmid:22186410
Conner TA et al. Effect of intravenous vitamin C on cytokine activation and oxidative stress in end-stage renal disease patients receiving intravenous iron sucrose. 2012 Biometals pmid:22706571
Walters KR et al. Methamphetamine causes anorexia in Drosophila melanogaster, exhausting metabolic reserves and contributing to mortality. 2012 J Toxicol Sci pmid:22863857
Bespalov VG and Aleksandrov VA [Anticarcinogenic effect of potassium salts of glucaric and glucuronic acid in induced models of cervical and esophageal tumors]. 2012 Vopr Onkol pmid:23607211
Araki T et al. Clinical efficacy of two forms of intravenous iron--saccharated ferric oxide and cideferron--for iron deficiency anemia. 2012 Pharmazie pmid:23346769
Lê BV et al. Modulation of Pseudomonas aeruginosa lipopolysaccharide-induced lung inflammation by chronic iron overload in rat. 2012 FEMS Immunol. Med. Microbiol. pmid:22066700
Smith TN et al. Modifications in the nitric acid oxidation of D-glucose. 2012 Carbohydr. Res. pmid:22285512
Kumbasar A et al. The effect of different doses and types of intravenous iron on oxidative stress and inflammation in hemodialysis patients. 2012 Sep-Oct J. Nephrol. pmid:22307439
Basora M et al. Optimizing preoperative haemoglobin with intravenous iron. 2013 Br J Anaesth pmid:23404979
Yamamoto S et al. Iatrogenic osteomalacia: report of two cases. 2013 J. UOEH pmid:23475021
García Erce JA et al. [Thoughts about the usefulness of the preoperatory administration of intravenous iron in hip fracture surgery]. 2013 Med Clin (Barc) pmid:23790583
Kowalczyk MC et al. Effects of combined phytochemicals on skin tumorigenesis in SENCAR mice. 2013 Int. J. Oncol. pmid:23835587
Beguin Y et al. Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation: a prospective multicenter randomized trial. 2013 Am. J. Hematol. pmid:23873823
Munoz C et al. Klotho sensitivity of the hERG channel. 2013 FEBS Lett. pmid:23603386
Lynn S and McDaniel J Managing severe anemia when the patient is a Jehovah's Witness. 2013 JAAPA pmid:23610833
Biggar P and Hahn KM [Importance of the different i.v. iron generations for everyday medical practice]. 2013 MMW Fortschr Med pmid:23678667
Beck-da-Silva L et al. IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia. 2013 Int. J. Cardiol. pmid:23680589
Wilson PD et al. An analysis of the health service efficiency and patient experience with two different intravenous iron preparations in a UK anaemia clinic. 2013 J Med Econ pmid:22989163
Douard V et al. Excessive fructose intake causes 1,25-(OH)(2)D(3)-dependent inhibition of intestinal and renal calcium transport in growing rats. 2013 Am. J. Physiol. Endocrinol. Metab. pmid:23571713
Yang Z et al. Parasitic nematode-induced modulation of body weight and associated metabolic dysfunction in mouse models of obesity. 2013 Infect. Immun. pmid:23509143
Potthoff SA and Münch HG [Safety aspects of parenteral iron supplementation therapies in patients with chronic kidney disease]. 2013 Dtsch. Med. Wochenschr. pmid:23737117
Janus N et al. Administration of intravenous iron complexes on implantable central venous access port in cancer patients in France: the FERPAC survey. 2013 Support Care Cancer pmid:23715817
Giger M and Achermann R [Iron substitution in outpatients in Switzerland: Increase of costs associated with intravenous administration]. 2013 Z Evid Fortbild Qual Gesundhwes pmid:23916272
Beck-da-Silva L et al. Iron therapy in patients with heart failure. A straight shot. 2013 Int. J. Cardiol. pmid:23931974
Vadasz D et al. Intravenous iron sucrose for restless legs syndrome in pregnant women with low serum ferritin. 2013 Sleep Med. pmid:24012019
Tian B et al. Predicting enzyme-substrate specificity with QM/MM methods: a case study of the stereospecificity of (D)-glucarate dehydratase. 2013 Biochemistry pmid:23901785
Abdel-Razeq H et al. Intravenous iron monotherapy for the treatment of non-iron-deficiency anemia in cancer patients undergoing chemotherapy: a pilot study. 2013 Drug Des Devel Ther pmid:24039403
Kalaivani K Use of intravenous iron sucrose for treatment of anaemia in pregnancy. 2013 Indian J. Med. Res. pmid:24056552
Kriplani A et al. Intravenous iron sucrose therapy for moderate to severe anaemia in pregnancy. 2013 Indian J. Med. Res. pmid:24056559
Michigami T [Updates on rickets and osteomalacia: FGF23-mediated hypophosphatemic rickets/osteomalacia]. 2013 Clin Calcium pmid:24076640
Ferumoxytol: an intravenous iron, riskier than iron sucrose. 2013 Prescrire Int pmid:24171212
Rowlands M et al. The effect of intravenous iron on postoperative transfusion requirements in hip fracture patients: study protocol for a randomized controlled trial. 2013 Trials pmid:24015990